Clinical and Economic Burden of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
- 14 October 2017
- journal article
- research article
- Published by Elsevier BV in Clinics in Liver Disease
- Vol. 22 (1), 1-10
- https://doi.org/10.1016/j.cld.2017.08.001
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Nonalcoholic Fatty Liver Disease, Diabetes Mellitus and Cardiovascular Disease: Newer DataInternational Journal of Endocrinology, 2013
- Non‐alcoholic fatty liver disease as an independent manifestation of the metabolic syndrome: Results of a US national survey in three ethnic groupsJournal of Gastroenterology and Hepatology, 2013
- Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosisNature Reviews Gastroenterology & Hepatology, 2013
- Ethnicity and nonalcoholic fatty liver diseaseHepatology, 2011
- Pathologic criteria for nonalcoholic steatohepatitis: Interprotocol agreement and ability to predict liver‐related mortalityHepatology, 2011
- National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participantsThe Lancet, 2011
- Correlates and Heritability of Nonalcoholic Fatty Liver Disease in a Minority CohortObesity, 2009
- Long-Term Follow-Up of Patients With Nonalcoholic Fatty LiverClinical Gastroenterology and Hepatology, 2008
- Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicityHepatology, 2004
- Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity☆, ☆☆Gastroenterology, 1999